Apolipoprotein E ε4 allele decreases functional connectivity in Alzheimer's disease as measured by EEG coherence

Journal of Neurology Neurosurgery and Psychiatry

Volumn 63, Issue 1, 1997, Pages 59-65

  Jelic, Vesna ^a,c   Julin, Per ^a   Shigeta, Masahiro ^b   Nordberg, Agneta ^a   Lannfelt, Lars ^a   Winblad, Bengt ^a   Wahlund, Lars Olof ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer's disease; Apolipoprotein E; EEG coherence; Quantitative electroencephalography

Indexed keywords

APOLIPOPROTEIN E4; APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ALPHA RHYTHM; ALZHEIMER DISEASE; ARTICLE; BETA RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ELECTROENCEPHALOGRAPHY; FEMALE; FRONTAL LOBE; GENOTYPE; HUMAN; MALE; OCCIPITAL LOBE; PARIETAL LOBE; PRIORITY JOURNAL; RISK FACTOR; TEMPORAL LOBE; BRAIN CORTEX; GENETICS; HEMISPHERIC DOMINANCE; MIDDLE AGED; ONSET AGE; PATHOPHYSIOLOGY; THETA RHYTHM;

AGE OF ONSET; AGED; ALLELES; ALPHA RHYTHM; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CEREBRAL CORTEX; ELECTROENCEPHALOGRAPHY; FEMALE; FUNCTIONAL LATERALITY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; THETA RHYTHM;

EID: 0030610592     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.63.1.59     Document Type: Article

References (37)

1. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD. Applipoprotein E: high-avidity binding to B-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-81.
2. Corder EH, Saunders AM, Strittmater WJ, Schmechel DE, Gaskel PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-3.
3. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele E4 with late-onset alzheimer's disease. Neurology 1993;43:1467-72.
4. Feskens EJM, Havekes LM, Kalmijn S, de Knijff P, Launer LJ, Kromhout D. Apolipoprotein e4 allele and cognitive decline in elderly men. BMJ 1994;309:1202-6.
5. Bondi MW, Salmon DP, Monsch AU, et al. Episodic memory changes are associated with the APOE-e4 allele in non-demented older adults. Neurology 1995;45:2203-6.
6. Reiman EM, Caselli RJ, Yun LS, et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the e4-allele for apolipoprotein E. N Engl J Med 1996;334:752-8.
7. Lehtovirta M, Soininen H, Helisalmi S, et al. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism. Neurology 1996;46:413-9.
8. Wisniewski T, Lalowski M, Golabek A, Vogel T, Frangione B. Is Alzheimer's disease an apolipoprotein E amyloidosis? Lancet 1995;345:956-8.
9. Polvikoski T, Sulkava R, Haltia M, et al. Apolipoprotein E, dementia, and cortical deposition of B-amyloid protein. N Engl J Med 1995;333:1242-7.
10. Lehtovirta M, Partanen J, Könönen M, et al. Spectral analysis in Alzheimer's disease: relation to apolipoprotein E polymorphism. Eur J Neurol 1995;2(suppl):129-30.
11. Duffy FH, Albert MS, McAnulty G. Brain electrical activity in patients with presenile and senile dementia of Alzheimer type. Ann Neurol 1984;16:439-48.
12. Soininen H, Partanen J, Laulumaa V, Pääkkönen A, Helkala E-L, Riekkinen PJ. Serial EEG in Alzheimer's disease: 3 year follow-up and clinical outcome. Electroencephalogr Clin Neurophysiol 1991;79:342-8.
13. Coben LA, Danziger WL, Berg L. Frequency analysis of the resting awake EEG in mild senile dementia of ALzheimer type. Electroencephalogr Clin Neurophysiol 1983;55:372-80.
14. Jelic V, Shigeta M, Julin P, Almkvist O, Winblad B, Wahlund L-O. Quantitative electroencephalography power and coherence in Alzheimer's disease and mild cognitive impairment. Dementia 1996;7:314-23.
15. Helkala E-L, Laulumaa V, Soininen H, Partanen J, Riekkinen PJ. Different patterns of cognitive decline related to normal or deteriorating EEG in a 3-year follow-up study of patients with Alzheimer's disease. Neurology 1991;41: 528-32.
16. Kuskowski MA, Mortimer JA, Morley GK, Malone SM, Okaya AJ. Rate of cognitive decline in Alzheimer's disease is associated with EEG α power. Biol Psychiatry 1993; 33:659-62.
17. Albert MS, Duffy FH, McAnulty GB. Electrophysiologic comparisions between two groups of patients with Alzheimer's disease. Arch Neurol 1990;47:857-63.
18. Schaw JC, O'Connor K, Ongley C. EEG coherence as a measure of cerebral functional organisation. In: Brazier MAB, Petsche H, eds. Architectonics of the cerebral cortex. New York: Raven Press, 1978:245-55.
19. Leuchter AF, Spar JE, Walter DO, Weiner H. Electroencephalographic spectra and coherence in the diagnosis of Alzheimer's-type and multiinfarct dementia: a pilot study. Arch Gen Psychiatry 1987;44:993-8.
20. Leuchter AF, Newton TF, Cook IA, Walter DO, Rosenberg-Thompson S, Lachenbruch PA. Changes in brain functional connectivity in Alzheimer-type and multi-infarct dementia. Brain 1992;115:1543-61.
21. Dierks T, Perisic I, Frölich L, Ihl L, Maurer K. Topography of the quantitative electroencephalogram in dementia of the Alzheimer type: relation to severity of dementia. Psychiatry Research: Neuroimaging 1991;40:181-94.
22. McKhann G, Drachman G, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services. Task Force on Alzheimer's disease. Neurology 1984;34:939-44.
23. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
24. Wechsler D. WAIS-R manual. New York: Psychological Corporation, 1981.
25. Bendat JS, Piersol AG. Random data: analysis and measurement procedures. New York: John Wiley, 1971:25-34; 337-42.
26. Pentilla M, Partanen JV, Soininen H, Riekkinen PJ. Quantitative analysis of occipital EEG in different stages of Alzheimer's disease. Electroencephal Clin Neurophysiol 1985;60:1-6.
27. Newton TF, Leuchter AF, Walter DO, et al. EEG coherence in men with AIDS: association with subcortical metabolic activity. J Neuropsychiatry Clin Neurosci 1993;5:316-21.
28. Besthorn C, Förstl H, Geiger-Kabish C, Sattel H, Gasser T, Schreiter-Gasser U. EEG coherence in Alzheimer disease. Electroencephalogr Clin Neurophysiol 1994;90:242-5.
29. Corder EH, Saunders AM, Strittmatter WJ, et al. Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology 1995;45:1323-8.
30. Basun H, Grut M, Winblad B, Lannfelt L. Apolipoprotein epsilon 4 allele and disease progression in patients with late-onser alzheimer's disease. Neurosci Lett 1995;183:32-4.
31. Dal Forno G, Rasmusson X, Brandt J, et al. Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. Arch Neurol 1996;53:345-50.
32. Leuchter AF, Dunkin JJ, Lufkin RB, Anzai Y, Cook IA, Newton TF. Effect of white matter disease on functional connections in the aging brain. J Neurol Neurosurg Psychiatry 1994;57:1347-54.
33. Frisoni GB, Calabresi L, Geroldi C, et al. Apolipoprotein E epsilon 4 allele in Alzheimer's disease and vascular dementia. Dementia 1994;5:240-2.
34. Myers RH, Schaefer EJ, Wilson PWF, et al. Apolipoprotein E e-4 association with dementia in a population-based study: the Framingham study. Neurology 1996;46:673-77.
35. Hendricks HT, Franke CL. Theunissen PHMH. Cerebral amyloid angiopathy: diagnosis by MRI and brain biopsy. Neurology 1990;40:1308-10.
36. Scheltens Ph, Barkhof F, Valk J, et al. White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Brain 1992;115:735-48.
37. De la Coste M-C, White CL. The role of cortical connectivity in Alzheimer's disease pathogenesis: a review and model system. Neurobiol Aging 1993;14:1-16.